 Patrick Carry
Concepts (418)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scoliosis | 12 | 2024 | 199 | 3.480 |
Why?
| | DNA Methylation | 7 | 2024 | 610 | 2.130 |
Why?
| | Islets of Langerhans | 5 | 2024 | 789 | 1.810 |
Why?
| | Acetabulum | 17 | 2024 | 106 | 1.720 |
Why?
| | Hip Dislocation, Congenital | 11 | 2023 | 37 | 1.630 |
Why?
| | Autoimmunity | 7 | 2024 | 862 | 1.500 |
Why?
| | Humeral Fractures | 8 | 2022 | 48 | 1.150 |
Why?
| | Diabetes Mellitus, Type 1 | 10 | 2024 | 3628 | 1.150 |
Why?
| | Spinal Fusion | 6 | 2022 | 228 | 1.130 |
Why?
| | Fractures, Bone | 8 | 2023 | 392 | 1.040 |
Why?
| | Orthopedic Procedures | 10 | 2020 | 208 | 1.010 |
Why?
| | Osteotomy | 11 | 2024 | 99 | 1.000 |
Why?
| | Adolescent | 64 | 2025 | 20303 | 0.960 |
Why?
| | Hip Dislocation | 9 | 2024 | 48 | 0.960 |
Why?
| | Hip Joint | 11 | 2022 | 158 | 0.890 |
Why?
| | Child | 63 | 2024 | 20773 | 0.850 |
Why?
| | Genome-Wide Association Study | 4 | 2024 | 1327 | 0.830 |
Why?
| | Propensity Score | 3 | 2023 | 263 | 0.800 |
Why?
| | Disease Progression | 5 | 2024 | 2630 | 0.780 |
Why?
| | Kyphosis | 1 | 2022 | 35 | 0.780 |
Why?
| | Blood Loss, Surgical | 3 | 2021 | 93 | 0.760 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 6 | 2019 | 124 | 0.750 |
Why?
| | Ultrasonic Therapy | 1 | 2021 | 11 | 0.730 |
Why?
| | Radiography | 21 | 2021 | 794 | 0.730 |
Why?
| | Brain Concussion | 6 | 2025 | 549 | 0.730 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.710 |
Why?
| | Twins, Monozygotic | 1 | 2021 | 209 | 0.680 |
Why?
| | Diseases in Twins | 1 | 2021 | 175 | 0.680 |
Why?
| | Semicircular Canals | 1 | 2020 | 29 | 0.660 |
Why?
| | Autoantibodies | 3 | 2024 | 1467 | 0.660 |
Why?
| | Athletic Injuries | 7 | 2025 | 510 | 0.650 |
Why?
| | Retrospective Studies | 54 | 2024 | 14455 | 0.650 |
Why?
| | Femoracetabular Impingement | 5 | 2020 | 34 | 0.650 |
Why?
| | Phospholipids | 1 | 2021 | 215 | 0.640 |
Why?
| | Return to Sport | 6 | 2025 | 90 | 0.640 |
Why?
| | Postoperative Complications | 18 | 2020 | 2473 | 0.640 |
Why?
| | Humans | 107 | 2025 | 129248 | 0.620 |
Why?
| | Ultrasonography | 6 | 2022 | 713 | 0.600 |
Why?
| | Surgeons | 1 | 2022 | 260 | 0.600 |
Why?
| | Upper Extremity | 2 | 2023 | 95 | 0.590 |
Why?
| | Joint Instability | 6 | 2022 | 166 | 0.570 |
Why?
| | Health Status | 1 | 2023 | 754 | 0.570 |
Why?
| | Female | 75 | 2025 | 68543 | 0.560 |
Why?
| | Child, Preschool | 21 | 2024 | 10456 | 0.550 |
Why?
| | Male | 75 | 2025 | 63501 | 0.550 |
Why?
| | Fracture Fixation | 3 | 2015 | 78 | 0.550 |
Why?
| | Algorithms | 2 | 2023 | 1613 | 0.530 |
Why?
| | Arteries | 1 | 2018 | 265 | 0.500 |
Why?
| | Fracture Fixation, Intramedullary | 4 | 2022 | 60 | 0.500 |
Why?
| | Femur | 5 | 2023 | 243 | 0.490 |
Why?
| | Clavicle | 3 | 2014 | 33 | 0.480 |
Why?
| | Tibial Fractures | 3 | 2023 | 72 | 0.480 |
Why?
| | Pain, Postoperative | 5 | 2018 | 233 | 0.450 |
Why?
| | Anterior Cruciate Ligament Injuries | 4 | 2019 | 140 | 0.440 |
Why?
| | Lower Extremity | 3 | 2023 | 404 | 0.430 |
Why?
| | Femur Head | 3 | 2021 | 36 | 0.430 |
Why?
| | Treatment Outcome | 31 | 2023 | 10199 | 0.410 |
Why?
| | Reoperation | 7 | 2024 | 541 | 0.400 |
Why?
| | Oxylipins | 3 | 2023 | 32 | 0.400 |
Why?
| | Snow Sports | 1 | 2012 | 2 | 0.390 |
Why?
| | Head Protective Devices | 1 | 2012 | 19 | 0.390 |
Why?
| | Femur Head Necrosis | 3 | 2016 | 7 | 0.390 |
Why?
| | Case-Control Studies | 9 | 2023 | 3377 | 0.390 |
Why?
| | Fracture Fixation, Internal | 7 | 2022 | 213 | 0.370 |
Why?
| | Epigenesis, Genetic | 4 | 2024 | 616 | 0.350 |
Why?
| | Epiphyses | 7 | 2021 | 20 | 0.350 |
Why?
| | Patellofemoral Pain Syndrome | 1 | 2010 | 6 | 0.350 |
Why?
| | Pronation | 1 | 2010 | 10 | 0.350 |
Why?
| | Patellofemoral Joint | 1 | 2010 | 9 | 0.340 |
Why?
| | Insulin | 2 | 2021 | 2325 | 0.340 |
Why?
| | Bone Nails | 4 | 2019 | 64 | 0.330 |
Why?
| | Osteogenesis Imperfecta | 2 | 2020 | 13 | 0.330 |
Why?
| | Magnetic Resonance Imaging | 6 | 2022 | 3386 | 0.320 |
Why?
| | Parent-Child Relations | 1 | 2012 | 256 | 0.320 |
Why?
| | Manipulation, Orthopedic | 3 | 2019 | 7 | 0.310 |
Why?
| | Severity of Illness Index | 7 | 2021 | 2737 | 0.300 |
Why?
| | Clubfoot | 2 | 2019 | 5 | 0.280 |
Why?
| | Casts, Surgical | 2 | 2019 | 26 | 0.280 |
Why?
| | Slipped Capital Femoral Epiphyses | 2 | 2018 | 6 | 0.270 |
Why?
| | Risk Factors | 16 | 2023 | 9745 | 0.260 |
Why?
| | Young Adult | 17 | 2024 | 12388 | 0.260 |
Why?
| | Spine | 2 | 2018 | 157 | 0.260 |
Why?
| | Cadaver | 3 | 2022 | 306 | 0.260 |
Why?
| | Cohort Studies | 8 | 2021 | 5408 | 0.260 |
Why?
| | Prevalence | 4 | 2022 | 2554 | 0.260 |
Why?
| | Sports | 2 | 2022 | 225 | 0.250 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 283 | 0.250 |
Why?
| | Clinical Protocols | 2 | 2018 | 254 | 0.250 |
Why?
| | Radiation Dosage | 2 | 2024 | 153 | 0.240 |
Why?
| | Charcot-Marie-Tooth Disease | 2 | 2016 | 21 | 0.240 |
Why?
| | Infant | 13 | 2023 | 8975 | 0.240 |
Why?
| | Athletes | 5 | 2022 | 409 | 0.230 |
Why?
| | Genetic Predisposition to Disease | 3 | 2023 | 2276 | 0.230 |
Why?
| | Tibia | 2 | 2023 | 170 | 0.230 |
Why?
| | Range of Motion, Articular | 7 | 2022 | 366 | 0.230 |
Why?
| | Tibial Meniscus Injuries | 2 | 2015 | 45 | 0.230 |
Why?
| | Cartilage, Articular | 2 | 2020 | 292 | 0.220 |
Why?
| | Elbow Joint | 3 | 2019 | 65 | 0.220 |
Why?
| | Proprioception | 1 | 2024 | 26 | 0.220 |
Why?
| | Sternoclavicular Joint | 2 | 2014 | 9 | 0.220 |
Why?
| | Biomechanical Phenomena | 6 | 2022 | 757 | 0.220 |
Why?
| | Dizziness | 1 | 2024 | 80 | 0.220 |
Why?
| | Radiation Exposure | 1 | 2024 | 45 | 0.220 |
Why?
| | Odds Ratio | 8 | 2019 | 1018 | 0.210 |
Why?
| | Time Factors | 13 | 2021 | 6543 | 0.210 |
Why?
| | Orthotic Devices | 3 | 2022 | 23 | 0.210 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 78 | 0.210 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 80 | 0.210 |
Why?
| | Adult | 20 | 2024 | 35495 | 0.210 |
Why?
| | Follow-Up Studies | 11 | 2024 | 4886 | 0.210 |
Why?
| | Cervical Vertebrae | 1 | 2024 | 131 | 0.210 |
Why?
| | Tomography, X-Ray Computed | 3 | 2019 | 2515 | 0.200 |
Why?
| | Humerus | 2 | 2022 | 41 | 0.200 |
Why?
| | Growth Plate | 2 | 2023 | 36 | 0.200 |
Why?
| | Meniere Disease | 1 | 2023 | 32 | 0.200 |
Why?
| | Ligaments, Articular | 1 | 2022 | 51 | 0.190 |
Why?
| | Gait Disorders, Neurologic | 1 | 2022 | 43 | 0.190 |
Why?
| | Wrist Joint | 1 | 2022 | 64 | 0.190 |
Why?
| | Hip Fractures | 1 | 2023 | 82 | 0.190 |
Why?
| | Spinal Fractures | 1 | 2023 | 82 | 0.190 |
Why?
| | Radius Fractures | 1 | 2022 | 58 | 0.190 |
Why?
| | Orthopedic Surgeons | 1 | 2022 | 25 | 0.190 |
Why?
| | Ankle Fractures | 1 | 2022 | 19 | 0.190 |
Why?
| | Legg-Calve-Perthes Disease | 1 | 2021 | 4 | 0.190 |
Why?
| | Deafness | 1 | 2023 | 80 | 0.190 |
Why?
| | Migraine Disorders | 1 | 2023 | 101 | 0.190 |
Why?
| | Quadriceps Muscle | 3 | 2022 | 128 | 0.180 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2021 | 45 | 0.180 |
Why?
| | Bone Plates | 2 | 2022 | 75 | 0.180 |
Why?
| | Selection Bias | 1 | 2021 | 37 | 0.180 |
Why?
| | Age Factors | 7 | 2021 | 3140 | 0.180 |
Why?
| | Orthognathic Surgical Procedures | 1 | 2001 | 5 | 0.180 |
Why?
| | Neck Muscles | 1 | 2021 | 18 | 0.180 |
Why?
| | Incidence | 8 | 2023 | 2636 | 0.180 |
Why?
| | Cerebral Palsy | 1 | 2022 | 96 | 0.180 |
Why?
| | Prosthesis Fitting | 1 | 2020 | 16 | 0.170 |
Why?
| | Suture Techniques | 2 | 2019 | 118 | 0.170 |
Why?
| | Lumbar Vertebrae | 1 | 2022 | 231 | 0.170 |
Why?
| | Arthralgia | 2 | 2020 | 49 | 0.170 |
Why?
| | Monitoring, Intraoperative | 2 | 2016 | 47 | 0.170 |
Why?
| | Probability | 1 | 2021 | 305 | 0.170 |
Why?
| | Longitudinal Studies | 2 | 2025 | 2716 | 0.170 |
Why?
| | Pelvic Bones | 1 | 2023 | 156 | 0.170 |
Why?
| | Bias | 1 | 2021 | 196 | 0.170 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1197 | 0.170 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 137 | 0.170 |
Why?
| | Muscle Strength | 2 | 2021 | 303 | 0.170 |
Why?
| | Intraoperative Complications | 1 | 2001 | 129 | 0.160 |
Why?
| | Patella | 1 | 2019 | 22 | 0.160 |
Why?
| | Recreation | 1 | 2019 | 21 | 0.160 |
Why?
| | Play and Playthings | 1 | 2019 | 33 | 0.160 |
Why?
| | Histology | 1 | 2019 | 4 | 0.160 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2019 | 11 | 0.160 |
Why?
| | Education, Professional | 1 | 2019 | 18 | 0.150 |
Why?
| | Health Occupations | 1 | 2019 | 30 | 0.150 |
Why?
| | Equipment Failure | 1 | 2019 | 105 | 0.150 |
Why?
| | Gene Frequency | 1 | 2020 | 502 | 0.150 |
Why?
| | Tendons | 1 | 2019 | 106 | 0.150 |
Why?
| | Prospective Studies | 8 | 2025 | 7121 | 0.150 |
Why?
| | Computer-Assisted Instruction | 1 | 2019 | 60 | 0.150 |
Why?
| | Logistic Models | 5 | 2017 | 1984 | 0.150 |
Why?
| | Interleukins | 1 | 2020 | 241 | 0.150 |
Why?
| | Anesthesia, Local | 1 | 2018 | 16 | 0.150 |
Why?
| | Pattern Recognition, Visual | 1 | 2019 | 98 | 0.150 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2018 | 11 | 0.150 |
Why?
| | Prader-Willi Syndrome | 1 | 2018 | 27 | 0.140 |
Why?
| | Genetic Association Studies | 1 | 2020 | 361 | 0.140 |
Why?
| | Femoral Nerve | 1 | 2018 | 16 | 0.140 |
Why?
| | Bone Malalignment | 1 | 2017 | 12 | 0.140 |
Why?
| | Arthroscopy | 2 | 2020 | 207 | 0.140 |
Why?
| | Analgesia, Epidural | 1 | 2018 | 23 | 0.140 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 352 | 0.140 |
Why?
| | Meningomyelocele | 1 | 2018 | 55 | 0.140 |
Why?
| | CpG Islands | 3 | 2023 | 152 | 0.140 |
Why?
| | Sciatic Nerve | 1 | 2018 | 56 | 0.140 |
Why?
| | Collagen | 1 | 2020 | 433 | 0.140 |
Why?
| | Femoral Fractures | 1 | 2018 | 73 | 0.140 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 101 | 0.140 |
Why?
| | Nerve Block | 1 | 2018 | 65 | 0.140 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 422 | 0.130 |
Why?
| | Learning Curve | 1 | 2017 | 68 | 0.130 |
Why?
| | Immunity, Innate | 1 | 2022 | 803 | 0.130 |
Why?
| | Epiphyses, Slipped | 1 | 2016 | 4 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 529 | 0.130 |
Why?
| | Cumulative Trauma Disorders | 1 | 2016 | 41 | 0.130 |
Why?
| | Open Fracture Reduction | 1 | 2016 | 31 | 0.130 |
Why?
| | Substance-Related Disorders | 1 | 2025 | 1019 | 0.130 |
Why?
| | ST Elevation Myocardial Infarction | 1 | 2016 | 52 | 0.130 |
Why?
| | Depression | 1 | 2025 | 1306 | 0.130 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5045 | 0.120 |
Why?
| | Pain | 1 | 2022 | 786 | 0.120 |
Why?
| | Metabolomics | 1 | 2021 | 652 | 0.120 |
Why?
| | Postoperative Hemorrhage | 1 | 2016 | 87 | 0.120 |
Why?
| | Electrocardiography | 2 | 2016 | 608 | 0.120 |
Why?
| | Radius | 1 | 2015 | 36 | 0.120 |
Why?
| | Shoulder Fractures | 1 | 2015 | 12 | 0.120 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 1946 | 0.120 |
Why?
| | Forecasting | 1 | 2016 | 359 | 0.120 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 66 | 0.120 |
Why?
| | United States | 10 | 2025 | 13828 | 0.120 |
Why?
| | Practice Patterns, Physicians' | 2 | 2015 | 1267 | 0.110 |
Why?
| | Soft Tissue Injuries | 1 | 2015 | 39 | 0.110 |
Why?
| | Caregivers | 1 | 2022 | 808 | 0.110 |
Why?
| | Elective Surgical Procedures | 1 | 2016 | 164 | 0.110 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2014 | 36 | 0.110 |
Why?
| | Menisci, Tibial | 1 | 2014 | 59 | 0.110 |
Why?
| | Unnecessary Procedures | 1 | 2015 | 48 | 0.110 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 275 | 0.110 |
Why?
| | Autografts | 1 | 2014 | 42 | 0.110 |
Why?
| | Long QT Syndrome | 1 | 2015 | 67 | 0.110 |
Why?
| | Bone Diseases | 1 | 2014 | 57 | 0.110 |
Why?
| | Patient Compliance | 1 | 2018 | 563 | 0.110 |
Why?
| | Diet | 1 | 2021 | 1212 | 0.110 |
Why?
| | Prescription Drugs | 1 | 2015 | 112 | 0.110 |
Why?
| | Venous Thrombosis | 1 | 2016 | 175 | 0.110 |
Why?
| | Allografts | 1 | 2014 | 136 | 0.110 |
Why?
| | Risk Assessment | 7 | 2017 | 3233 | 0.110 |
Why?
| | Obesity | 3 | 2015 | 2879 | 0.110 |
Why?
| | Joint Dislocations | 1 | 2014 | 50 | 0.110 |
Why?
| | Exercise | 1 | 2025 | 1925 | 0.110 |
Why?
| | Cartilage | 1 | 2015 | 181 | 0.110 |
Why?
| | Pulmonary Embolism | 1 | 2016 | 211 | 0.110 |
Why?
| | Shoulder Dislocation | 1 | 2014 | 49 | 0.100 |
Why?
| | Injury Severity Score | 3 | 2023 | 509 | 0.100 |
Why?
| | Clinical Competence | 2 | 2017 | 1016 | 0.100 |
Why?
| | Chi-Square Distribution | 4 | 2015 | 514 | 0.100 |
Why?
| | Body Mass Index | 3 | 2016 | 2272 | 0.100 |
Why?
| | Intra-Articular Fractures | 1 | 2012 | 19 | 0.100 |
Why?
| | Bupivacaine | 1 | 2012 | 30 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 4 | 2016 | 851 | 0.100 |
Why?
| | Pediatrics | 1 | 2020 | 1047 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2063 | 0.100 |
Why?
| | Anemia, Sickle Cell | 1 | 2015 | 252 | 0.100 |
Why?
| | Amides | 1 | 2012 | 91 | 0.100 |
Why?
| | Bone and Bones | 1 | 2014 | 295 | 0.090 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1497 | 0.090 |
Why?
| | Treatment Failure | 3 | 2019 | 339 | 0.090 |
Why?
| | Knee Joint | 3 | 2022 | 372 | 0.090 |
Why?
| | Graft Survival | 1 | 2014 | 511 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2015 | 526 | 0.090 |
Why?
| | Operative Time | 3 | 2017 | 124 | 0.090 |
Why?
| | Recovery of Function | 4 | 2016 | 641 | 0.090 |
Why?
| | Gait | 2 | 2025 | 278 | 0.090 |
Why?
| | Linear Models | 3 | 2021 | 819 | 0.090 |
Why?
| | Reproducibility of Results | 4 | 2020 | 3079 | 0.090 |
Why?
| | Emergency Medical Services | 1 | 2016 | 521 | 0.090 |
Why?
| | Craniocerebral Trauma | 1 | 2012 | 151 | 0.090 |
Why?
| | Aged, 80 and over | 2 | 2021 | 7055 | 0.080 |
Why?
| | North America | 1 | 2011 | 291 | 0.080 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 909 | 0.080 |
Why?
| | Trauma Centers | 2 | 2022 | 402 | 0.080 |
Why?
| | Torque | 2 | 2021 | 82 | 0.080 |
Why?
| | Sex Factors | 3 | 2021 | 1965 | 0.080 |
Why?
| | Data Collection | 1 | 2012 | 647 | 0.080 |
Why?
| | Health Care Surveys | 1 | 2011 | 557 | 0.080 |
Why?
| | Neuromuscular Diseases | 1 | 2010 | 105 | 0.080 |
Why?
| | Mice | 2 | 2023 | 16915 | 0.080 |
Why?
| | Facial Bones | 2 | 2001 | 28 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2439 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1702 | 0.070 |
Why?
| | Postoperative Care | 3 | 2015 | 241 | 0.070 |
Why?
| | Equipment Failure Analysis | 2 | 2020 | 131 | 0.070 |
Why?
| | Observer Variation | 2 | 2018 | 315 | 0.070 |
Why?
| | Self Report | 2 | 2025 | 795 | 0.070 |
Why?
| | Regression Analysis | 2 | 2019 | 991 | 0.070 |
Why?
| | Bone Transplantation | 2 | 2019 | 83 | 0.070 |
Why?
| | Equipment Design | 2 | 2019 | 513 | 0.060 |
Why?
| | Hemodilution | 2 | 1996 | 9 | 0.060 |
Why?
| | Patient Care Team | 1 | 2010 | 601 | 0.060 |
Why?
| | Prognosis | 3 | 2020 | 3772 | 0.060 |
Why?
| | Infant, Newborn | 4 | 2019 | 5736 | 0.060 |
Why?
| | Animals | 2 | 2023 | 35307 | 0.050 |
Why?
| | Knee Injuries | 2 | 2015 | 99 | 0.050 |
Why?
| | Vestibule, Labyrinth | 1 | 2024 | 66 | 0.050 |
Why?
| | Fluoroscopy | 1 | 2024 | 156 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 81 | 0.050 |
Why?
| | Middle Aged | 7 | 2022 | 31087 | 0.050 |
Why?
| | Reaction Time | 1 | 2025 | 410 | 0.050 |
Why?
| | X-Rays | 1 | 2022 | 27 | 0.050 |
Why?
| | Operating Rooms | 1 | 2024 | 115 | 0.050 |
Why?
| | Vertigo | 1 | 2023 | 38 | 0.050 |
Why?
| | Pain Measurement | 2 | 2018 | 506 | 0.050 |
Why?
| | Colorado | 3 | 2018 | 4406 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2023 | 120 | 0.050 |
Why?
| | Patient Satisfaction | 2 | 2018 | 632 | 0.050 |
Why?
| | Pelvis | 1 | 2023 | 104 | 0.050 |
Why?
| | Physical Therapy Modalities | 2 | 2015 | 291 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 143 | 0.050 |
Why?
| | Fracture Healing | 1 | 2022 | 75 | 0.050 |
Why?
| | Anatomic Variation | 1 | 2021 | 3 | 0.050 |
Why?
| | Catheters | 1 | 2022 | 66 | 0.050 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 65 | 0.050 |
Why?
| | Peripheral Nerves | 1 | 2022 | 69 | 0.050 |
Why?
| | Standard of Care | 1 | 2022 | 71 | 0.050 |
Why?
| | Preanesthetic Medication | 1 | 2001 | 3 | 0.050 |
Why?
| | Chin | 1 | 2001 | 5 | 0.050 |
Why?
| | Osteotomy, Le Fort | 1 | 2001 | 3 | 0.050 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2001 | 11 | 0.050 |
Why?
| | Pulmonary Atelectasis | 1 | 2001 | 13 | 0.050 |
Why?
| | Linoleic Acid | 1 | 2021 | 41 | 0.040 |
Why?
| | Malocclusion | 1 | 2001 | 25 | 0.040 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 63 | 0.040 |
Why?
| | Muscle Strength Dynamometer | 1 | 2021 | 22 | 0.040 |
Why?
| | Arachidonic Acid | 1 | 2021 | 115 | 0.040 |
Why?
| | Osteogenesis, Distraction | 1 | 2001 | 12 | 0.040 |
Why?
| | Work | 1 | 2020 | 17 | 0.040 |
Why?
| | Musculoskeletal System | 1 | 2021 | 46 | 0.040 |
Why?
| | Anesthesia, General | 1 | 2001 | 54 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 166 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 82 | 0.040 |
Why?
| | Blood | 1 | 2001 | 105 | 0.040 |
Why?
| | Emergency Service, Hospital | 2 | 2023 | 1896 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.040 |
Why?
| | Functional Laterality | 1 | 2020 | 222 | 0.040 |
Why?
| | Patellar Ligament | 1 | 2019 | 25 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2001 | 100 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 569 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2019 | 50 | 0.040 |
Why?
| | Students | 1 | 2025 | 579 | 0.040 |
Why?
| | Athletic Performance | 1 | 2020 | 77 | 0.040 |
Why?
| | Educational Status | 1 | 2022 | 469 | 0.040 |
Why?
| | Fetal Blood | 1 | 2021 | 317 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 756 | 0.040 |
Why?
| | Sutures | 1 | 2019 | 53 | 0.040 |
Why?
| | Ligaments | 1 | 2019 | 54 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 138 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 580 | 0.040 |
Why?
| | Isometric Contraction | 1 | 2021 | 187 | 0.040 |
Why?
| | Students, Health Occupations | 1 | 2019 | 29 | 0.040 |
Why?
| | Eye Movements | 1 | 2019 | 59 | 0.040 |
Why?
| | Anterior Cruciate Ligament | 1 | 2019 | 80 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 630 | 0.040 |
Why?
| | Comorbidity | 2 | 2015 | 1544 | 0.040 |
Why?
| | Professional Competence | 1 | 2019 | 94 | 0.040 |
Why?
| | Random Allocation | 1 | 2019 | 346 | 0.040 |
Why?
| | Video Recording | 1 | 2019 | 163 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 523 | 0.040 |
Why?
| | Breast Feeding | 1 | 2021 | 423 | 0.040 |
Why?
| | Thoracic Vertebrae | 1 | 2018 | 71 | 0.040 |
Why?
| | Risk Management | 1 | 2018 | 85 | 0.030 |
Why?
| | Organ Size | 1 | 2018 | 446 | 0.030 |
Why?
| | Device Removal | 1 | 2018 | 136 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2018 | 233 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1212 | 0.030 |
Why?
| | Age of Onset | 1 | 2018 | 496 | 0.030 |
Why?
| | Intestinal Fistula | 1 | 1996 | 15 | 0.030 |
Why?
| | Ileostomy | 1 | 1996 | 20 | 0.030 |
Why?
| | Intracranial Pressure | 1 | 2016 | 45 | 0.030 |
Why?
| | Ribs | 1 | 2015 | 33 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1266 | 0.030 |
Why?
| | Inservice Training | 1 | 2016 | 112 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2016 | 124 | 0.030 |
Why?
| | Missouri | 1 | 2015 | 69 | 0.030 |
Why?
| | Methylprednisolone | 1 | 1996 | 83 | 0.030 |
Why?
| | Intestinal Obstruction | 1 | 1996 | 49 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 304 | 0.030 |
Why?
| | Postoperative Period | 1 | 2016 | 329 | 0.030 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1497 | 0.030 |
Why?
| | Matched-Pair Analysis | 1 | 2015 | 40 | 0.030 |
Why?
| | Titanium | 1 | 2015 | 76 | 0.030 |
Why?
| | Radiologic Health | 1 | 2015 | 4 | 0.030 |
Why?
| | Rotation | 1 | 2015 | 111 | 0.030 |
Why?
| | Curettage | 1 | 2014 | 8 | 0.030 |
Why?
| | Esthetics | 1 | 2015 | 49 | 0.030 |
Why?
| | Transplantation, Autologous | 1 | 2015 | 211 | 0.030 |
Why?
| | Medical Records | 1 | 2015 | 170 | 0.030 |
Why?
| | Skull | 1 | 1996 | 129 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 2015 | 104 | 0.030 |
Why?
| | Lysholm Knee Score | 1 | 2014 | 8 | 0.030 |
Why?
| | Pain Management | 1 | 2018 | 324 | 0.030 |
Why?
| | Cost Savings | 1 | 2015 | 78 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 502 | 0.030 |
Why?
| | Coxa Valga | 1 | 2014 | 1 | 0.030 |
Why?
| | Edema | 1 | 1995 | 124 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 2016 | 463 | 0.030 |
Why?
| | Immobilization | 1 | 2014 | 45 | 0.030 |
Why?
| | Physical Examination | 1 | 2015 | 234 | 0.030 |
Why?
| | Age Distribution | 1 | 2015 | 372 | 0.030 |
Why?
| | Occupational Therapy | 1 | 2015 | 85 | 0.030 |
Why?
| | Sex Distribution | 1 | 2015 | 359 | 0.030 |
Why?
| | Finite Element Analysis | 1 | 2014 | 72 | 0.030 |
Why?
| | Face | 1 | 1995 | 165 | 0.030 |
Why?
| | Osteoarthritis, Hip | 1 | 2014 | 43 | 0.030 |
Why?
| | Hospitalization | 1 | 2023 | 2052 | 0.030 |
Why?
| | Preoperative Care | 1 | 2015 | 339 | 0.030 |
Why?
| | Injections, Intra-Articular | 1 | 2012 | 46 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 1996 | 480 | 0.020 |
Why?
| | Anesthetics, Local | 1 | 2012 | 75 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2012 | 271 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 2685 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 588 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1091 | 0.020 |
Why?
| | Patient Selection | 1 | 2014 | 662 | 0.020 |
Why?
| | Communication | 1 | 2016 | 836 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 768 | 0.020 |
Why?
| | Quality Improvement | 1 | 2018 | 1095 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1288 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2012 | 508 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2008 | 0.020 |
Why?
| | Lung | 1 | 2001 | 3926 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 5382 | 0.020 |
Why?
| | Aged | 2 | 2022 | 22032 | 0.020 |
Why?
| | Acute-Phase Proteins | 2 | 1996 | 67 | 0.020 |
Why?
| | Critical Care | 1 | 2010 | 551 | 0.020 |
Why?
| | Length of Stay | 1 | 2010 | 1120 | 0.010 |
Why?
| | Inflammation | 1 | 1996 | 2737 | 0.010 |
Why?
| | Orosomucoid | 1 | 1995 | 6 | 0.010 |
Why?
| | Telemetry | 1 | 1995 | 39 | 0.010 |
Why?
| | Blood Volume | 1 | 1995 | 60 | 0.010 |
Why?
| | Hematocrit | 1 | 1995 | 93 | 0.010 |
Why?
| | Haptoglobins | 1 | 1995 | 52 | 0.010 |
Why?
| | Mandible | 1 | 1995 | 61 | 0.010 |
Why?
| | Morbidity | 1 | 1996 | 300 | 0.010 |
Why?
| | Rectal Neoplasms | 1 | 1996 | 136 | 0.010 |
Why?
| | Colitis, Ulcerative | 1 | 1996 | 118 | 0.010 |
Why?
| | Fibrinogen | 1 | 1995 | 163 | 0.010 |
Why?
| | C-Reactive Protein | 1 | 1995 | 400 | 0.010 |
Why?
| | Crohn Disease | 1 | 1996 | 215 | 0.010 |
Why?
|
|
Carry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|